Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 14, 2012 - Issue 2
Submit an article Journal homepage
527
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin

Seung-Phil HongDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;Department of Dermatology, Dankook University Hospital, Cheonan, Korea
,
Seung-Seog HanI Dermatology Clinic, Seoul, Korea
,
Seok-Joo ChoiDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Myoung-Shin KimDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Chong-Hyun WonDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Mi-Woo LeeDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Jee-Ho ChoiDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Kee-Chan MoonDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Youn Jin KimPureen Dermatology Clinic, Seoul, Korea
&
Sung-Eun ChangDepartment of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 81-86 | Received 11 Oct 2011, Accepted 28 Dec 2011, Published online: 28 Feb 2012

References

  • Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006;55:1048–1065.
  • Nanda S, Grover C, Reddy BS. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma. Dermatol Surg. 2004;30:385–388; discussion 389.
  • Kalla G, Garg A, Kachhawa D. Chemical peeling—glycolic acid versus trichloroacetic acid in melasma. Indian J Dermatol Venereol Leprol. 2001;67:82–84.
  • Obagi ZE, Obagi S, Alaiti S, Stevens MB. TCA-based blue peel: A standardized procedure with depth control. Dermatol Surg. 1999;25:773–780.
  • Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol. 2006;54:S272–S281.
  • Tannous ZS, Astner S. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther. 2005;7:39–43.
  • Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg. 2005;31:1645–1650.
  • Lee HS, Won CH, Lee DH, An JS, Chang HW, Lee JH, . Treatment of melasma in Asian skin using a fractional 1,550-nm laser: An open clinical study. Dermatol Surg. 2009;35:1499–1504.
  • Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM. Treatment of melasma using fractional photothermolysis: A report of eight cases with long-term follow-up. Dermatol Surg. 2010;36:1273–1280.
  • Kroon MW, Wind BS, Beek JF, Van der Veen JPW, Nieuweboer-Krobotova L, Bos JD, . Nonablative fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study. J Am Acad Dermatol. 2011;64:516–523.
  • Wind BS, Kroon MW, Meesters AA, Beek JF, van der Veen JP, Nieuweboer-Krobotova L, . Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split-face study. Laser Surg Med. 2010;42:607–612.
  • Tierney EP, Hanke CW. Review of the literature: Treatment of dyspigmentation with fractionated resurfacing. Dermatol Surg. 2010;36:1499–1508.
  • Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese females. J Cosmet Laser Ther. 2007;9:161–163.
  • Kawada A, Kawara S, Oiso N, Endo H, Yoshinaga E, Konishi N, . An evaluation of whitening effect of an intense ulsed light source using computer analysis of the video-captured digital image. Arch Dermatol Res. 2008;300(Suppl 1):S39–S41.
  • Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, . Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727–733.
  • Safoury OS, Zaki NM, El Nabarawy EA, Farag EA. A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. Indian J Dermatol. 2009; 54:41–45.
  • Soliman MM, Ramadan SA, Bassiouny DA, Abdelmalek M. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: A comparative study. J Cosmet Dermatol. 2007;6:89–94.
  • Azzam OA, Leheta TM, Nagui NA, Shaarawy E, Hay RM, Hilal RF. Different therapeutic modalities for treatment of melasma. J Cosmet Dermatol. 2009;8:275–281.
  • Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001;40:354–357.
  • Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: A comparative study. Dermatol Surg. 2002;28:828–832; discussion 832.
  • Hantash BM, Bedi VP, Sudireddy V, Struck SK, Herron GS, Chan KF. Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Optic. 2006;11:041115.
  • Goldberg DJ, Berlin AL, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Laser Surg Med. 2008;40:134–138.
  • Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, . Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237.
  • Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, . The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154:1094–1099.
  • Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
  • Ho SG, Chan HH. The Asian dermatologic patient: Review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10:153–168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.